Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19
Ivan Fan-Ngai Hung, Kwok-Cheung Lung, Eugene Yuk-Keung Tso et al The Lancet DOI: https://doi.org/10.1016/S0140-6736(20)31042-4 A multicentre, prospective, open-label, randomised, phase 2 trial in adults with COVID-19 who were admitted Continue Reading →